CDKN2A and acute lymphoblastic leukemia: However, the PDX lines selected are broadly representative, harboring a combination of frequent NOTCH1 and/or FBXW7 mutations, biallelic CDKN2A loss, and wildtype TP53; all T-ALL genetic hallmarks.